SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-043867
Filing Date
2019-09-09
Accepted
2019-09-09 08:30:19
Documents
6
Period of Report
2019-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv529014_8k.htm 8-K 51049
2 EXHIBIT 3.1 tv529014_ex3-1.htm EX-3.1 65932
3 EXHIBIT 3.2 tv529014_ex3-2.htm EX-3.2 7205
4 EXHIBIT 4.1 tv529014_ex4-1.htm EX-4.1 303922
5 GRAPHIC tv529014_ex4-1img1.jpg GRAPHIC 3632
6 GRAPHIC tv529014_ex4-1img2.jpg GRAPHIC 10496
  Complete submission text file 0001144204-19-043867.txt   449282
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38045 | Film No.: 191081192
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1